Selective Anticancer Therapy Using Pro-Oxidant Drug-Loaded Chitosan–Fucoidan Nanoparticles

Pro-oxidant therapy exploiting pro-oxidant drugs that can trigger cytotoxic oxidative stress in cancer cells has emerged as an innovative strategy for cancer-specific therapy. Piperlongumine (PL) has gained great interest as a novel pro-oxidant agent, because it has an ability to trigger cancer-spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Dae Gun, Venkatesan, Jayachandran, Shim, Min Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651851/
https://www.ncbi.nlm.nih.gov/pubmed/31262038
http://dx.doi.org/10.3390/ijms20133220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651851/
https://www.ncbi.nlm.nih.gov/pubmed/31262038
http://dx.doi.org/10.3390/ijms20133220

Ejemplares similares